About Cytel Inc.

Cytel Inc. is the leading provider of clinical trial design services and specialized statistical applications for the biopharmaceutical, medical device, academic, and government research markets. Cytel’s East® system is used by biostatisticians and clinicians at hundreds at commercial sites, throughout academia and by regulators to design, simulate and monitor group sequential and adaptive clinical trials. Cytel provides trial sponsors with innovative tools, training, and consultation to increase process efficiencies and reduce development costs.

Products & Services

Cytel Inc. has a 20-year track record as the premier provider of software and services for the design and analysis of clinical trials. Cytel provides the applications, training, and consultation to clinical trial sponsors seeking to increase trial efficiencies and reduce drug development costs in phase 1, 2 and 3 studies. Cytel’s East® system is used by biostatisticians and cliniciansat hundreds of in industry, academia and every major branch of the FDA to design, simulate and monitor group sequential and adaptive clinical trials. Over 10,000 customers also use Cytel’s award-winning StatXact®, and LogXact® applications for exact statistical inference.

The company’s Pharmaceutical Research Division, established in 2005, is now a key contributor to Cytel's growth. This unit offers the following major service lines: clinical trial design and simulation, independent statistical center, SAS programming support, custom applications development, strategic clinical technology consulting, and training.

Cytel’s products and services are sold worldwide through a direct sales and business development team coupled with an inside sales force, global distributor network, Internet sales, and OEM arrangements. The company forecasts continued strong demand for both products and services.

With groundbreaking solutions, highly-respected founders and advisory board members, a top-notch management team, and a customer base that includes most of the world’s leading biopharmaceutical companies, Cytel is well positioned for long-term growth and market leadership.